Bespoke Extracts, Inc. (BSPK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bespoke Extracts, Inc. (BSPK) trades at $0.13 with AI Score 65/100 (Grade B+). Bespoke Extracts, Inc. specializes in hemp-derived cannabidiol (CBD) products, including unique manuka honey formulations, topicals, capsules, and gummies. Market cap: $1.47M, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for BSPK: BSPK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BSPK against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
BSPK: 2/4 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Bespoke Extracts, Inc. (BSPK) Healthcare & Pipeline Overview
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products, encompassing manuka honey formulations, lotions, balms, capsules, and gummies. Operating via a direct-to-consumer e-commerce platform, the company positions itself within the healthcare sector's specialty and generic drug industry, focusing on diverse product offerings and online retail for consumer wellness.
What Is the Investment Thesis for BSPK?
Bespoke Extracts, Inc. (BSPK) presents an investment profile centered on its direct-to-consumer model within the expanding hemp-derived cannabidiol (CBD) market. The company's focus on a diverse product range, including unique formulations like CBD manuka honey, alongside capsules, topicals, and gummies, positions it to address varied consumer preferences. A key value driver is its gross margin of 47.2%, which indicates a healthy profitability at the product level, despite an overall profit margin of -51.3%, reflecting its early-stage or small-scale operational costs. The direct-to-consumer e-commerce strategy, bespokeextracts.com, offers potential for scalable growth without extensive physical retail infrastructure. Growth catalysts include the increasing mainstream acceptance and regulatory clarity surrounding CBD products, which could expand the total addressable market. Furthermore, the company's ability to innovate with new product formulations and optimize its digital marketing efforts could drive customer acquisition and retention. However, the company's small operational scale, with only 2 employees, and its OTC market classification introduce significant operational and liquidity risks. The current market capitalization of $1.47M also indicates a very early-stage or illiquid equity, requiring investors to consider the high-risk, high-reward nature typical of micro-cap companies in emerging sectors.
Based on FMP financials and quantitative analysis
BSPK Key Highlights
- Market Capitalization of $1.47M, indicating a micro-cap or illiquid equity.
- Profit Margin of -51.3%, reflecting current operational unprofitability.
- Gross Margin of 47.2%, demonstrating healthy profitability at the product level.
- Beta of 0.18, suggesting low volatility relative to the broader market.
- Operates with a lean team of 2 employees, emphasizing a small operational footprint.
Who Are BSPK's Competitors?
BSPK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.05M | 64 |
| AVDL Avadel Pharmaceuticals plc | $21.64 | +0.00% | $2.12B | 64 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.34M | 63 |
| CAMRF Camurus AB (publ) | $60.00 | -1.66% | $3.60B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BSPK's Key Strengths?
- Direct-to-consumer e-commerce model provides broad reach and potentially higher margins.
- Diverse product portfolio including unique formulations like CBD manuka honey.
- Healthy gross margin of 47.2% indicates strong product-level profitability.
- Agile operational structure with a small team allows for quick adaptation.
What Are BSPK's Weaknesses?
- Negative profit margin of -51.3% indicates overall unprofitability.
- Extremely small scale with only 2 employees, limiting capacity and resources.
- Trades on the OTC market ("OTC Other"), implying lower liquidity and transparency.
- Market capitalization of $1.47M suggests minimal market valuation or trading activity.
What Could Drive BSPK Stock Higher?
- Continued operation and optimization of its direct-to-consumer e-commerce platform, bespokeextracts.com, driving sales of CBD products.
- Potential introduction of new CBD product formulations or expansion into additional wellness categories to diversify revenue streams.
- Increased consumer adoption and broader market acceptance of hemp-derived CBD products, expanding the total addressable market.
- Any positive shifts in the regulatory landscape for CBD, potentially enabling wider marketing and distribution opportunities.
What Are the Key Risks for BSPK?
- Persistent negative profit margin of -51.3% indicating operational unprofitability and potential for ongoing losses.
- Intense competition within the fragmented and rapidly growing hemp-derived CBD market.
- Regulatory changes or increased scrutiny that could impact the production, marketing, or sale of CBD products.
- Limited operational scale with only 2 employees, posing challenges for growth, innovation, and managing increased demand.
- Low liquidity and transparency due to trading on the "OTC Other" market, affecting investor confidence and capital access.
What Are the Growth Opportunities for BSPK?
- Expansion of Product Portfolio and Formulations: Bespoke Extracts has an opportunity to expand its current range of CBD products beyond manuka honey, lotions, balms, capsules, and gummies. Developing new delivery methods, higher potency options, or targeted formulations for specific wellness needs (e.g., sleep, anxiety, pain relief) could capture new market segments. The global market for CBD-infused products is continuously innovating, with new applications emerging in areas like functional beverages, pet care, and cosmetics. By investing in research and development, Bespoke Extracts could introduce proprietary blends or novel product categories, potentially increasing its market share and appealing to a broader consumer base seeking specialized wellness solutions. This could unfold over the next 2-5 years.
- Optimization and Scaling of Direct-to-Consumer E-commerce Channel: The company's existing direct-to-consumer e-commerce store, bespokeextracts.com, represents a significant growth opportunity. By investing in advanced digital marketing strategies, search engine optimization (SEO), social media engagement, and customer relationship management (CRM) systems, Bespoke Extracts can enhance its online visibility and conversion rates. Expanding its digital footprint through strategic partnerships with online wellness platforms or influencers could also drive traffic and sales. The e-commerce segment of the CBD market is projected to continue its robust growth, offering a cost-effective channel for reaching consumers nationwide. Improving the user experience and streamlining the purchasing process can lead to increased customer loyalty and lifetime value over the next 1-3 years.
- Leveraging Brand Recognition and Customer Loyalty: As Bespoke Extracts continues to operate, building a strong brand identity and fostering customer loyalty can be a powerful growth driver. In a crowded CBD market, a trusted brand with consistent product quality and effective customer service can stand out. Implementing loyalty programs, subscription services, and personalized marketing campaigns can encourage repeat purchases and word-of-mouth referrals. Positive customer reviews and testimonials on its e-commerce platform can also serve as social proof, attracting new customers. This focus on brand equity and customer retention is a continuous, ongoing opportunity that strengthens the company's market position over the long term.
- Strategic Partnerships and Distribution Agreements: While currently focused on direct-to-consumer sales, Bespoke Extracts could explore strategic partnerships to expand its reach. Collaborations with complementary wellness brands, health food stores, or specialized clinics could open new distribution channels. For instance, partnering with a chain of holistic health practitioners could provide a new avenue for product sales and endorsements. Such partnerships could also involve co-branding opportunities or white-label agreements, allowing the company to leverage existing market access and credibility. These types of alliances could significantly accelerate market penetration and brand exposure, potentially materializing within the next 3-5 years.
- Capitalizing on Evolving Regulatory Landscape: The regulatory environment for CBD products in the United States and globally is continually evolving. As more clarity and standardization emerge, it could create a more stable and predictable market for companies like Bespoke Extracts. Potential federal legalization or clearer guidelines from regulatory bodies could reduce operational uncertainties and open doors to broader marketing and distribution opportunities. Companies that are well-positioned with compliant products and transparent practices stand to benefit significantly from such shifts. Bespoke Extracts, by maintaining high product standards and staying abreast of regulatory developments, could capitalize on a more mature and regulated market, which is an ongoing opportunity with potential significant shifts over the next 5-10 years.
What Opportunities Does BSPK Have?
- Growing global market for hemp-derived CBD products driven by increasing consumer acceptance.
- Potential for product line expansion into new delivery methods or targeted wellness solutions.
- Optimization of e-commerce platform and digital marketing to enhance customer acquisition.
- Strategic partnerships could expand distribution and brand visibility.
What Threats Does BSPK Face?
- Intense competition from numerous established and emerging CBD brands.
- Uncertain and evolving regulatory landscape for CBD products.
- Potential for market saturation and price erosion in the CBD sector.
- Limited access to capital and funding challenges typical for micro-cap OTC companies.
What Are BSPK's Competitive Advantages?
- Direct-to-Consumer E-commerce Channel: Establishes a direct relationship with customers, potentially leading to higher margins and better data insights compared to wholesale models.
- Specialized Product Formulations: Offers unique products like CBD-infused manuka honey, which may differentiate it from generic CBD offerings.
- Brand Recognition (Developing): As an early-stage company, consistent product quality and customer experience can build a loyal customer base over time.
What Does BSPK Do?
Bespoke Extracts, Inc. (BSPK) is a healthcare sector entity primarily engaged in the provision of hemp-derived cannabidiol (CBD) products. The company's product portfolio is diverse, encompassing various CBD formulations designed to cater to a broad consumer base. These offerings include unique products such as CBD-infused manuka honey, alongside more traditional applications like CBD lotions and balms for topical use. Furthermore, Bespoke Extracts markets CBD extracts in convenient capsule form, as well as popular consumable formats like gummies, providing multiple delivery methods for its consumers. The company operates predominantly through a direct-to-consumer e-commerce store, bespokeextracts.com, which serves as its primary sales channel. This online model allows Bespoke Extracts to reach a wide audience directly, bypassing traditional retail intermediaries and potentially fostering a closer relationship with its customer base. Headquartered in Aurora, US, with its business description noting Denver, Colorado, the company maintains a lean operational structure, employing 2 individuals. Bespoke Extracts, Inc. has undergone a corporate identity evolution; it was formerly known as DiMi Telematics International, Inc. The strategic decision to rebrand and change its name to Bespoke Extracts, Inc. occurred in March 2017, signaling a definitive pivot towards its current focus on the CBD market. This transformation underscores the company's commitment to the rapidly evolving landscape of hemp-derived products. By concentrating on specialized CBD formulations and leveraging a direct digital sales approach, Bespoke Extracts aims to carve out a distinct position within the competitive drug manufacturers - specialty & generic industry. Its operational model emphasizes accessibility and variety in its CBD product line, targeting consumers seeking wellness solutions within the burgeoning market for cannabinoid-based offerings.
What Products and Services Does BSPK Offer?
- Provides hemp-derived cannabidiol (CBD) products.
- Offers CBD formulations including unique manuka honey blends.
- Markets CBD in topical forms such as lotions and balms.
- Sells CBD extracts in convenient capsule form.
- Distributes CBD in popular edible formats like gummies.
- Operates a direct-to-consumer e-commerce store, bespokeextracts.com.
- Focuses on the specialty and generic drug segment within healthcare.
- Manages a lean operational structure with 2 employees.
How Does BSPK Make Money?
- Direct-to-Consumer Sales: Generates revenue primarily through its e-commerce platform, bespokeextracts.com, selling directly to end-users.
- Product Sales: Profits from the sale of various hemp-derived CBD products, including capsules, topicals, gummies, and specialized formulations.
- Brand and Product Differentiation: Aims to attract and retain customers through unique product offerings like CBD manuka honey and a diverse product line.
What Industry Does BSPK Operate In?
Bespoke Extracts, Inc. operates within the "Drug Manufacturers - Specialty & Generic" industry, specifically targeting the rapidly evolving market for hemp-derived cannabidiol (CBD) products. This segment is part of the broader healthcare sector, experiencing significant growth driven by increasing consumer interest in wellness and alternative therapies. The global CBD market size was valued at approximately $12.8 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of over 20% through 2030, indicating substantial expansion potential. BSPK's direct-to-consumer e-commerce model places it in direct competition with numerous online retailers and established brands, both large and small, that offer similar CBD products. The competitive landscape is fragmented and characterized by varying product quality, branding strategies, and regulatory compliance levels. Bespoke Extracts aims to differentiate itself through specialized formulations, such as manuka honey-infused CBD, and a diverse product line, including capsules, topicals, and gummies, catering to a niche within this competitive environment.
Who Are BSPK's Key Customers?
- Wellness-Oriented Consumers: Individuals seeking natural or alternative solutions for health and wellness.
- Online Shoppers: Consumers comfortable purchasing health and supplement products through e-commerce channels.
- CBD Enthusiasts: Existing users of CBD products looking for new formulations or trusted brands.
- Specific Needs Segments: Customers interested in targeted applications of CBD, such as topical relief or ingestible supplements.
F-Score 4/9Financial Health
Bespoke Extracts, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
ROE 31%Key Financial Metrics
Return on equity for Bespoke Extracts, Inc. stands at 30.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -11.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.11 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -32.5%, the inverse of the P/E and a quick read on earnings relative to price.
Bespoke Extracts, Inc. (BSPK) Valuation Context
Valued at $1.47M, BSPK is classified as a micro-cap stock. Relative to its peer group, BSPK's quantitative score of 65/100 is roughly in line with the peer average of 67/100.
BSPK Revenue & Earnings Trend
In Q3 2025, BSPK generated $468K in top-line revenue, marking a sequential increase of 19.8%. The company recorded a net loss of $78K, with diluted EPS of $-0.01. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Healthcare company. Across the four most recent quarters, BSPK averaged $-0.02 in diluted EPS.
Company Profile
Bespoke Extracts, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Aurora, US. The company is led by CEO Michael R. Feinsod. BSPK has traded publicly since 2008.
BSPK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Direct-to-consumer e-commerce model provides broad reach and potentially higher margins.
- Diverse product portfolio including unique formulations like CBD manuka honey.
- Healthy gross margin of 47.2% indicates strong product-level profitability.
- Agile operational structure with a small team allows for quick adaptation.
Bear Case
- Negative profit margin of -51.3% indicates overall unprofitability.
- Extremely small scale with only 2 employees, limiting capacity and resources.
- Trades on the OTC market ("OTC Other"), implying lower liquidity and transparency.
- Market capitalization of $1.47M suggests minimal market valuation or trading activity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $467,945 | -$78,088 | -$0.01 |
| Q2 2025 | $390,553 | -$205,106 | -$0.02 |
| Q1 2025 | $263,159 | -$260,521 | -$0.02 |
| Q4 2024 | $301,390 | -$186,849 | -$0.02 |
Based on FMP financials and quantitative analysis
BSPK Latest News
No recent news available for BSPK.
BSPK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BSPK.
Price Targets
Wall Street price target analysis for BSPK.
BSPK MoonshotScore
What does this score mean?
The MoonshotScore rates BSPK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Michael R. Feinsod
Chief Executive Officer
Michael R. Feinsod serves as the Chief Executive Officer of Bespoke Extracts, Inc., leading a lean operational team of 2 employees. His leadership is central to the company's strategic direction and day-to-day operations in the hemp-derived CBD product market. While specific details regarding his prior career history, educational background, or previous executive roles are not provided, his current position involves steering the company's direct-to-consumer e-commerce strategy and overseeing its product development in the specialty and generic drug industry. His role encompasses managing the entirety of the company's limited human resources to achieve its business objectives within a competitive and evolving sector.
Track Record: Under Michael R. Feinsod's leadership, Bespoke Extracts, Inc. has focused on developing and marketing a range of hemp-derived CBD products since its name change in March 2017. He has overseen the establishment of the company's direct-to-consumer e-commerce platform, bespokeextracts.com, as the primary sales channel. His strategic decisions have centered on offering diverse CBD formulations, including unique manuka honey products, capsules, topicals, and gummies, aiming to cater to a broad consumer base within the wellness sector.
BSPK OTC Market Information
Bespoke Extracts, Inc. trades on the "OTC Other" tier of the OTC Markets. This tier is typically for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or choose not to provide financial information to the public markets. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding financial performance, corporate governance, and public disclosure, "OTC Other" companies have minimal or, in some cases, no reporting obligations. This classification often indicates a higher level of risk due to limited transparency and oversight, making it challenging for investors to access comprehensive financial and operational data.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public disclosure and transparency, making due diligence challenging.
- Extremely low trading volume and liquidity, leading to difficulty in buying or selling shares.
- Higher volatility and susceptibility to manipulation due to less regulatory oversight.
- Difficulty in obtaining financing and attracting institutional investment.
- Lack of analyst coverage and readily available market information.
- Verify any available financial statements directly from company sources, if published.
- Research management's background and track record beyond what is publicly stated.
- Assess the company's product efficacy and market demand through independent reviews.
- Investigate any past or ongoing legal or regulatory actions against the company.
- Evaluate the competitive landscape and the company's true differentiation.
- Understand the specific risks associated with the CBD industry's regulatory environment.
- Confirm the company's operational status and actual sales activity.
- Operates an active e-commerce website (bespokeextracts.com) for direct sales.
- Has a defined product line of hemp-derived CBD products.
- Underwent a name change in 2017, indicating a strategic business pivot.
- Headquartered in Aurora, US, suggesting a physical presence.
Common Questions About BSPK (Healthcare)
What does Bespoke Extracts, Inc. do?
Bespoke Extracts, Inc. (BSPK) specializes in the development and direct-to-consumer sales of hemp-derived cannabidiol (CBD) products. The company offers a diverse range of CBD formulations, including unique offerings like CBD-infused manuka honey, alongside more conventional products such as topical lotions and balms. Additionally, Bespoke Extracts markets CBD extracts in capsule form for ingestible consumption and popular edible gummies. Its primary business model leverages an e-commerce platform, bespokeextracts.com, to reach customers directly. This approach allows the company to operate within the specialty and generic drug manufacturing segment of the healthcare sector, focusing on the burgeoning wellness market for cannabinoid-based solutions.
What are the key growth opportunities for BSPK in the healthcare sector?
In the healthcare sector, Bespoke Extracts, Inc. has several key growth opportunities. One significant area is the expansion of its product portfolio by developing new CBD formulations or venturing into related wellness product categories, capitalizing on the increasing consumer demand for natural health solutions. Another opportunity lies in optimizing and scaling its direct-to-consumer e-commerce channel through enhanced digital marketing and customer engagement strategies, which can broaden its market reach without extensive physical infrastructure. Furthermore, as regulatory clarity surrounding CBD products continues to evolve, Bespoke Extracts could benefit from a more stable market environment, potentially unlocking wider distribution and marketing avenues within the healthcare and wellness industries.
What are the primary risks associated with investing in Bespoke Extracts, Inc. given its market classification?
Investing in Bespoke Extracts, Inc. carries several primary risks, particularly due to its "OTC Other" market classification and its operational profile. The company's negative profit margin of -51.3% indicates ongoing unprofitability, raising concerns about its long-term financial sustainability. As an "OTC Other" stock, BSPK faces significantly lower liquidity and transparency compared to exchange-listed companies, making it challenging for investors to buy or sell shares efficiently and assess fair value. The extremely small operational scale, with only 2 employees, presents inherent limitations in capacity, innovation, and ability to withstand competitive pressures or market downturns. Moreover, the CBD industry itself is subject to evolving and often uncertain regulatory frameworks, which could impact product legality, marketing, and sales channels.
How does Bespoke Extracts, Inc. differentiate its CBD products in the market?
Bespoke Extracts, Inc. aims to differentiate its CBD products through a combination of unique formulations and a direct-to-consumer sales model. The company stands out by offering specialized products such as CBD-infused manuka honey, which provides a distinct offering compared to more generic CBD oils or tinctures. Beyond this, its diverse product line, encompassing lotions, balms, capsules, and gummies, caters to a wide array of consumer preferences for delivery methods and applications. By selling directly through its e-commerce platform, bespokeextracts.com, the company can control the customer experience, gather direct feedback, and potentially build a stronger brand identity and loyalty in a crowded market. This direct approach, coupled with specific product innovation, forms the core of its differentiation strategy.
What is the financial performance outlook for Bespoke Extracts, Inc.?
Based on the provided financials, Bespoke Extracts, Inc. exhibits a mixed performance profile. The company maintains a healthy gross margin of 47.2%, indicating that its core product sales are profitable before accounting for operating expenses. However, this positive gross margin is overshadowed by a significant negative profit margin of -51.3%, suggesting that operational costs, administrative expenses, or other factors are leading to overall unprofitability. With a market capitalization of $1.47M and only 2 employees, the company is at a very early or micro-cap stage, implying limited revenue generation and significant challenges in scaling operations to achieve profitability. The financial outlook would depend heavily on its ability to increase sales volume, manage operating expenses efficiently, and potentially secure further funding to support growth initiatives.
What are the key factors to evaluate for BSPK?
Bespoke Extracts, Inc. (BSPK) holds an AI score of 65/100 (moderate). Not financial advice.
How frequently does BSPK data refresh on this page?
BSPK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BSPK's recent stock price performance?
Bespoke Extracts, Inc. (BSPK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Direct-to-consumer e-commerce model provides broad reach and potentially higher margins. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.